期刊
FEBS LETTERS
卷 589, 期 1, 页码 77-83出版社
WILEY
DOI: 10.1016/j.febslet.2014.11.026
关键词
Tau protein; Tau oligomers; Aggregation inhibitors; (-)-Epigallocatechin gallate; Alzheimer's disease; Polyphenol
资金
- Nationales Genomforschungsnetz Plus Grant [01GS08132]
- Deutsche Forschungsgemeinschaft Grant [BI1409-1/2]
- Helmholtz Alliance for Mental Health in an Ageing Society - HelMA
- NINDS [1R01NS071835]
- Tau Consortium
The accumulation of amyloid-beta (Ab) and tau aggregates is a pathological hallmark of Alzheimer's disease. Both polypeptides form fibrillar deposits, but several lines of evidence indicate that Ab and tau form toxic oligomeric aggregation intermediates. Depleting such structures could thus be a powerful therapeutic strategy. We generated a fragment of tau (His-K18 Delta K280) that forms stable, toxic, oligomeric tau aggregates in vitro. We show that (-)-epigallocatechin gallate (EGCG), a green tea polyphenol that was previously found to reduce Ab aggregation, inhibits the aggregation of tau K18 Delta K280 into toxic oligomers at ten-to hundred-fold substoichiometric concentrations, thereby rescuing toxicity in neuronal model cells. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据